Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Raw Materials: 2010-2025

Historic Raw Materials for BIO-TECHNE (TECH) over the last 15 years, with Sep 2025 value amounting to $94.0 million.

  • BIO-TECHNE's Raw Materials rose 14.93% to $94.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.0 million, marking a year-over-year increase of 14.93%. This contributed to the annual value of $89.1 million for FY2025, which is 12.22% up from last year.
  • According to the latest figures from Q3 2025, BIO-TECHNE's Raw Materials is $94.0 million, which was up 5.52% from $89.1 million recorded in Q2 2025.
  • Over the past 5 years, BIO-TECHNE's Raw Materials peaked at $94.0 million during Q3 2025, and registered a low of $51.7 million during Q1 2021.
  • Moreover, its 3-year median value for Raw Materials was $84.0 million (2024), whereas its average is $84.7 million.
  • Per our database at Business Quant, BIO-TECHNE's Raw Materials soared by 43.91% in 2022 and then declined by 7.45% in 2024.
  • BIO-TECHNE's Raw Materials (Quarterly) stood at $61.6 million in 2021, then skyrocketed by 37.54% to $84.8 million in 2022, then dropped by 1.78% to $83.2 million in 2023, then climbed by 0.86% to $84.0 million in 2024, then climbed by 14.93% to $94.0 million in 2025.
  • Its last three reported values are $94.0 million in Q3 2025, $89.1 million for Q2 2025, and $83.5 million during Q1 2025.